WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005016282) PRKCS AS MODIFIERS OF THE BETA CATENIN PATHWAY AND METHODS OF USE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/016282    International Application No.:    PCT/US2004/026361
Publication Date: 24.02.2005 International Filing Date: 13.08.2004
IPC:
C12Q 1/48 (2006.01), G01N 33/574 (2006.01), C07K 16/00 (2006.01), C12Q 1/00 (2006.01)
Applicants: EXELIXIS, INC. [US/US]; 170 Harbor Way, P.O. Box 511, South San Francisco, California 94083-0511 (US) (For All Designated States Except US).
FRANCIS-LANG, Helen [GB/US]; (US) (For US Only).
WINTER, Christopher G. [US/US]; (US) (For US Only).
VENTURA, Richard Benn Abegania [US/US]; (US) (For US Only).
HEUER, Timothy S. [US/US]; (US) (For US Only).
ADAMKEWICZ, Joanne I. [US/US]; (US) (For US Only)
Inventors: FRANCIS-LANG, Helen; (US).
WINTER, Christopher G.; (US).
VENTURA, Richard Benn Abegania; (US).
HEUER, Timothy S.; (US).
ADAMKEWICZ, Joanne I.; (US)
Agent: SHAYESTEH, Laleh; 170 Harbor Way, P.O. Box 511, South San Francisco, CA 94083-0511 (US)
Priority Data:
60/495,172 14.08.2003 US
Title (EN) PRKCS AS MODIFIERS OF THE BETA CATENIN PATHWAY AND METHODS OF USE
(FR) PRKC UTILISES EN TANT QUE MODIFICATEURS DE LA VOIE BETA CATENINE ET METHODES D'UTILISATION ASSOCIEES
Abstract: front page image
(EN)Human PRKC genes are identified as modulators of the beta catenin pathway, and thus are therapeutic targets for disorders associated with defective beta catenin function. Methods for identifying modulators of beta catenin, comprising screening for agents that modulate the activity of PRKC are provided.
(FR)L'invention concerne des gènes PRKC humains identifiés comme modulateurs de la voie bêta caténine, constituant des cibles thérapeutiques pour les troubles liés à une fonction bêta caténine déficiente. L'invention concerne également des méthodes d'identification des modulateurs de la bêta caténine. Ces méthodes consistent à cribler des agents modulant l'activité des PRKC.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)